Can open-source R&D reinvigorate drug research?
- 18 August 2006
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 5 (9) , 723-729
- https://doi.org/10.1038/nrd2131
Abstract
The low number of novel therapeutics approved by the US FDA in recent years continues to cause great concern about productivity and declining innovation. Can open-source drug research and development, using principles pioneered by the highly successful open-source software movement, help revive the industry?Keywords
This publication has 11 references indexed in Scilit:
- An enhanced version of SMMP—open-source software package for simulation of proteinsComputer Physics Communications, 2006
- Optimizing the use of open-source software applications in drug discoveryDrug Discovery Today, 2006
- The Major Role of Clinicians in the Discovery of Off-Label Drug TherapiesSSRN Electronic Journal, 2005
- Technology Licensing to Non-Traditional PartnersIndustry and Higher Education, 2005
- Open-source software: not quite endsvilleDrug Discovery Today, 2005
- The case for open-source software in drug discoveryDrug Discovery Today, 2005
- Finding Cures for Tropical Diseases: Is Open Source an Answer?PLoS Medicine, 2004
- Virtual drug discovery and development for neglected diseases through public–private partnershipsNature Reviews Drug Discovery, 2003
- 11. Major Discoveries and Biomedical Research Organizations: Perspectives on Interdisciplinarity, Nurturing Leadership, and Integrated Structure and CulturesPublished by University of Toronto Press Inc. (UTPress) ,2000
- Networks of innovators :A review and introduction to the issueResearch Policy, 1991